Eptifibatide
- Generic Name
- Eptifibatide
- Brand Names
- Integrilin, Eptifibatide Accord
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 188627-80-7
- Unique Ingredient Identifier
- NA8320J834
- Background
Synthetic cyclic hexapeptide that binds to platelet receptor glycoprotein and inhibits platelet aggregation. Derived from venom of the Southeastern pygmy rattlesnake (Sistrurus miliarus barbouri), eptifibatide is a cyclic heptapeptide that belongs to the class of arginin-glycin-aspartat-mimetics.
- Indication
For treatment of myocardial infarction and acute coronary syndrome.
- Associated Conditions
- Acute Coronary Syndrome (ACS), Percutaneous Coronary Intervention (PCI)
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath